drugset / Trial / NCT01508260

Ultrafiltration (Aquapheresis) in Patients With Leukemia and Severe Fluid Overload

NCT01508260

RandomizedParallel-groupOpen-labelTreatment

Summary

The goal of this clinical research study is to learn about the safety and level of effectiveness of aquapheresis compared to diuretic drugs. Diuretic drugs are designed to help the kidneys to form more urine. They also remove fluids from patients with severe fluid overload who have not responded to diuretics. Aquapheresis is a procedure that removes excess fluid from the body. Blood containing too much salt and water is withdrawn from the body using catheters (sterile flexible tubes) and passed through a special filter. The filter separates the excess salt and water from the blood. The blood is returned to the patient and the fluid is collected in a bag to be disposed. Aquapherisis may benefit patients by removing excess fluid and salt from the body.

Timeline

Start
2013-03
Primary completion
2018-03
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Furosemide Other / unclassified 0.5 mg Intravenous
Comparator Furosemide Other / unclassified 5 mg Intravenous
Comparator Furosemide Other / unclassified 20 mg Intravenous
Comparator Furosemide Other / unclassified 40 mg Intravenous

Indications